Clinical perspective: The importance of heart rate reduction in heart failure

International Journal of Clinical Practice

Volumn 66, Issue 8, 2012, Pages 728-730

  Cowie, M R ^a   Davidson, L ^b  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IVABRADINE; PLACEBO;

ASTHMA; BRADYCARDIA; COMORBIDITY; DRUG MECHANISM; DRUG TOLERABILITY; DRUG WITHDRAWAL; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HUMAN; HYPOTENSION; KIDNEY DYSFUNCTION; LOW DRUG DOSE; MORBIDITY; MORTALITY; PRESCRIPTION; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; REVIEW; SURVIVAL; WHEEZING;

EID: 84863907252     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2012.02968.x     Document Type: Review

References (16)

1. Pocock SJ, Wang D, Pfeffer MA, et al., Predictors of mortality and morbidity in patients with chronic heart failure. Eur Heart J 2006; 27: 65-75. (Pubitemid 41785934)
2. Lechat P, Hulot J-S, Escolano S, et al., Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II trial. Circulation 2001; 103: 1428-33. (Pubitemid 32220636)
3. Bohm M, Swedberg K, Komadja M, et al., Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial. Lancet 2010; 376: 886-94.
4. Perski A, Olsson G, Landou C, de Faire U, Theorell T, Hamsten A,. Minimum heart rate and coronary atherosclerosis: independent relations to global severity and rate of progression of angiographic lesions in men with myocardial infarction at a young age. Am Heart J 1992; 123: 609-16.
5. Kjekshus J, Gullestad L,. Heart rate as a therapeutic target in heart failure. Eur Heart J 1999; 1 (Suppl. H): H64-9. (Pubitemid 29304286)
6. McAlister FA, Wiebe N, Ezekowit JA, Leung AA, Armstrong PW,. Meta-analysis: beta-blocker dose, heart rate reduction and death in patients with heart failure. Ann Intern Med 2009; 150: 784-94.
7. Thollon C, Cambarrat C, Vian J, Prost JF, Peglion JL, Vilaine JP,. Electrophysiological effects of S 16257, a novel sino-atrial node modulator, on rabbit and guinea-pig cardiac preparations: comparisons with UL-FS 49. Br J Pharmacol 1994; 112: 37-42. (Pubitemid 24151700)
8. Swedberg K, Komadja M, Bohm M, et al., Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo controlled study. Lancet 2010; 376: 875-85.
9. Dickstein K, Cohen-Solal A, Filippatos G, et al., ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. Eur Heart J 2008; 29: 2388-442.
10. Tardiff JC, O'Meara E, Komajda M, et al., Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy. Eur Heart J 2011; 32: 2507-15.
11. Ekman I, Chassany O, Komajda M, et al., Heart rate reduction with ivabradine and health related quality of life in patients with chonic heart failure: results from the SHIFT study. Eur Heart J 2011; 32: 2395-404.
12. National Heart Failure Audit report, April 2010-March 2011. National Institutes for Cardiovascular Outcomes Research; 2012.
13. Setakis E, Kassianos G, Cockle S, Van Staa TP, Morley C,. Beta-blocker doses in coronary heart disease patients treated in UK primary care. Eur Heart J 2009; 30 (Abstract Suppl): 511.
14. Setakis E, Morely C, Cockle S, Van Staa TP, Kassianos G,. Persistence with beta-blockers in coronary heart disease patients in UK primary care. Eur Heart J 2009; 30 (Abstract Suppl): 303.
15. Maggioni AP, Dahlstrom U, Filipattos G, et al., EURObservational research programme: The Heart Failure Pilot Survey (ESC-HF Pilot). Eur J Heart Fail 2010; 12: 1076-84.
16. Assyag P, De Groote P, Galinier M, et al., Temporal trends in prescription rates of recommended treatments in chronic heart failure outpatients: a comparison of three French surveys IMPACT RECO I, II and III. Eur J Heart Fail 2009; 8 (Suppl): ii730. abstract 1444.